Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis

Abstract

Transforming growth factor (TGF)-β signaling plays an important role in the pathogenesis of psoriasis. CD109, a novel TGF-β co-receptor, which inhibits TGF-β signaling by enhancing Smad7-dependent degradation of TGF-β type I receptor (TGF-β RI), is abnormally expreβsed in psoriasis. To date, the expreβsion of Smad7 and the correlation between CD109 and Smad7 expreβsion in psoriasis have not been fully elucidated. This study was designed to investigate the expreβsion and the correlation of CD109 and TGF-β signaling aβsociated proteins in psoriasis and their roles in the pathogenesis of psoriasis. Thirty-two psoriasis specimens were subjected to immunohistochemical staining for CD109, Smad7, TGF-β RI and Ki67. Ten normal skin (NS) specimens served as controls. The positive expression rate (% positive cells) of Smad7 and Ki67 in psoriasis was significantly higher than in NS (62.6%±19.9% vs. 17.2%±4.4%, and 50.7%±14.3% vs. 19.5%±3.2%, respectively, P<0.001), and the expression levels of CD109 and TGF-β R? were reduced significantly in psoriasis as compared with NS (8.1%±6.7% vs. 35.8%±6.7% and 27.3%±3.4% vs. 3.0%±3.4%, respectively, P<0.001). There were significantly negative correlations between CD109 and Smad7 (r=-0.831, P<0.01). These findings indicated that CD109 might play a certain role in the pathogenesis of psoriasis. Lower expression of CD109 and TGF-β RI was highly correlated with higher expression of Smad7 and Ki67, suggesting that CD109 may induce the pathogenesis of psoriasis through Smad7-mediated degradation of TGF-β RI, and lead to the termination of TGF-β signaling.

Keywords

psoriasis / CD109 / transforming growth factor beta / signal transduction / Smad7

References

[1] NestleFO, KaplanDH, BarkerJ. Psoriasis. N Engl J Med, 2009, 361(15): 496-509 PMID: 19641206

[2] YueJ, MulderKM. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther, 2001, 91(1): 1-34 PMID: 11707292

[3] BiernackaA, DobaczewskiM, FrangogiannisNG. TGF-β signaling in fibrosis. Growth Factors, 2011, 29(5): 196-202 PMCID: 4408550 PMID: 21740331

[4] PennJW, GrobbelaarAO, RolfeKJ. The role of the TGF-β family in wound healing, burns and scarring: a review. Int J Burns Trauma, 2012, 2(1): 18-28 PMCID: 3415964 PMID: 22928164

[5] BuβseA, KeilholzU. Role of TGF-β in melanoma. Curr Pharm Biotechnol, 2011, 12(12): 2165-2175

[6] ZhangY, MengXM, HuangXR, et al. . Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice. Clin Exp Pharmacol Physiol, 2014, 41(11): 921-932 PMID: 25132073

[7] ShiY, MassaguéJ. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 2003, 113(6): 685-700 PMID: 12809600

[8] DoiH, ShibataMA, KiyokaneK, et al. . Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris. J Dermatol Sci, 2003, 33(1): 7-16 PMID: 14527734

[9] ChongPA, LinH, WranaJL, et al. . An expanded WW domain recognition motif revealed by the interaction between Smad7 and the E3 ubiquitin ligase Smurf2. J Biol Chem, 2006, 281(25): 17 069-17 075

[10] LuoL, LiN, LvN, et al. . SMAD7: a timer of tumor progreβsion targeting TGF-β signaling. Tumour Biol, 2014, 35(9): 8379-8385 PMID: 24935472

[11] LinM, SutherlandDR, HorsfallW, et al. . Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins. Blood, 2002, 99(5): 1683-1691 PMID: 11861284

[12] MokrosinskiJ, KrajewskaWM. TGF beta signalling accessory receptors. Postepy Biochem, 2008, 54(3): 264-273 PMID: 19112825

[13] HashimotoM, IchiharaM, WatanabeT, et al. . Expression of CD109 in human cancer. Oncogene, 2004, 23(20): 3716-3720 PMID: 15116102

[14] OhshimaY, YajimaI, KumasakaMY, et al. . CD109 expression levels in malignant melanoma. J Dermatol Sci, 2010, 57(2): 140-142 PMID: 20034764

[15] OzbayP, EkinciT, YigitS, et al. . Investigation of prognostic significance of CD109 expression in women with vular squamous cell carcinoma. Onco Targets Ther, 2013, 6: 621-627 PMCID: 3681417 PMID: 23776335

[16] FinnsonKW, TamBY, LiuK, et al. . Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. FASEB J, 2006, 20(9): 1525-1527 PMID: 16754747

[17] BizetAA, LiuK, Tran-KhanhN, et al. . The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors. Biochim Biophys Acta, 2011, 1813(5): 742-753 PMID: 21295082

[18] BizetAA, Tran-KhanhN, SaksenaA, et al. . CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function. J Cell Biochem, 2012, 113(1): 238-246 PMID: 21898545

[19] LitvinovIV, BizetAA, BinamerY, et al. . CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expreβsion. TGF-β signalling and STAT3 activation: relevance to psoriasis. Exp Dermatol, 2011, 20(8): 627-632 PMID: 21539622

[20] TamBY, PhilipA. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins. J Cell Physiol, 1998, 176(3): 553-564 PMID: 9699508

[21] HagiwaraS, MurakumoY, MiiS, et al. . Processing of CD109 by furin and its role in the regulation of TGF-beta signaling. Oncogene, 2010, 29(15): 2181-2191 PMID: 20101215

[22] JinninM. Mechanisms of skin fibrosis in systemic sclerosis. J Dermatol, 2010, 37(1): 11-25 PMID: 20175837

[23] ManXY, FinnsonKW, BaronM, et al. . CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts. Arthritis Res Ther, 2012, 14(3): R144 PMCID: 3446527 PMID: 22694813

[24] LeivoT, LeivoI, KariniemiAL, et al. . Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis. Br J Dermatol, 1998, 138(1): 57-62 PMID: 9536223

[25] FengAP, HeYM, LiuXX, et al. . Expreβsion of USP15, TβR-I and Smad7 in psoriasis. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(3): 415-419 PMID: 24939309

[26] KavsakP, RasmussenRK, CausingCG, et al. . Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell, 2000, 6(6): 1365-1375 PMID: 11163210

[27] EbisawaT, FukuchiM, MurakamiG, et al. . Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem, 2001, 276(16): 12477-12480 PMID: 11278251